Notice Type
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:


Product: Panadol Extra
Active Ingredients: Caffeine 65mg
Paracetamol 500mg
Dosage Form: Film coated tablet
New Zealand Sponsor: GlaxoSmithKline Consumer Healthcare New Zealand ULC
Manufacturer: GlaxoSmithKline Dungarvan Limited, Dungarvan, Ireland
Product: Tysabri
Active Ingredient: Natalizumab 20mg/mL
Dosage Form: Solution for infusion
New Zealand Sponsor: Biogen NZ Biopharma Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany

Dated this 4th day of May 2020.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).